BEGLAN 25 micrograms/inhalation, pressurized inhaler suspension

2. What you need to know before you start using Beglan

Do not use Beglan

• if you are allergic to salmeterol or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before you start using Beglan:

• If you have ever had to stop taking any other medicine for your condition due to allergy problems or other reasons.
• If you are being treated for any thyroid problems.
• If you are being treated for high blood pressure.
• If you are being treated for heart problems.
• If you have diabetes mellitus.
• If you have a tendency to have low potassium levels in your blood.
• If you are being treated with ketoconazole (a medicine used to treat fungal infections).

If you are using Beglan for the treatment of your asthma, your doctor will want to see you regularly to check your symptoms. Go to your doctor immediately if:

• Your asthma gets worse.
• You have more difficulty breathing.
• You notice more wheezing.
• You have a feeling of shortness of breath more often.
• You need to use your rescue medication more frequently.

If you experience any of the above situations, do not increase the number of applications of Beglan (your respiratory condition may worsen and you may become seriously ill). Go to your doctor as you may need to have your medication changed for the treatment of your asthma.

Patients who have previously been treated with Beglan should know that it no longer contains chlorofluorocarbons (CFCs) as propellants. It should be used exactly as your doctor indicates. Your doctor may change your dosage regimen.

The active ingredient of CFC-free Beglan is exactly the same as that of Beglan that contained CFCs. The only differences you may notice are the taste and the sensation of feeling the spray in your mouth, as well as the sound of the inhaler during use. This is due to the change of propellant to eliminate CFCs. This modification does not affect the mechanism of action of the drug. CFC-free Beglan can be used in the same way as the previous one.

Other medicines and Beglan

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Important information about some of the ingredients of Beglan

Use in athletes: this medicine contains salmeterol, which may produce a positive result in doping tests.

3. How to use Beglan

Follow the instructions for administration of this medicine exactly as your doctor has told you. If you are in doubt, consult your doctor or pharmacist again.

Remember to use your medicine. IT IS VERY IMPORTANT THAT YOU USE IT REGULARLY EVERY DAY. This will help you stay free of symptoms throughout the day and night.

Your doctor will tell you how long to use Beglan. Do not stop treatment before, even if you feel better, unless your doctor tells you to.

Beglan should only be used by inhalation and should not be used in children under 4 years of age.

If you have been prescribed Beglan for your asthma, you should continue to use any other medication you are taking to control your asthma. These should include an inhaled corticosteroid or tablets. Continue to take the same doses as before, unless your doctor tells you otherwise. Do this even if you feel better. Do not stop taking your inhaled corticosteroid (or tablets) when you start using Beglan.

It is very important that you follow your doctor's instructions about how many times and how often you should use Beglan. The instructions for use are given below. If you have difficulties or do not understand the instructions, ask your doctor or pharmacist.

The recommended dose is:

Adults

• Two inhalations (50 micrograms) twice a day. If your doctor advises you to, you can increase this dose up to four inhalations (100 micrograms) twice a day.

Use in children and adolescents

• Children over 4 years: two inhalations (50 micrograms) twice a day.

If you think the effect of Beglan is too strong or too weak, tell your doctor or pharmacist.

Instructions for use:

Before using the inhaler for the first time or if it has not been used for a week or more, remove the mouthpiece cover by squeezing gently on the sides, shake the inhaler well, and release two applications into the air to ensure the inhaler is working.

Using the inhaler:

1. Remove the mouthpiece cover by squeezing gently on the sides.

1. Check that there are no foreign particles inside and outside the inhaler, including the mouthpiece.

1. Shake the inhaler well to ensure that any foreign particles are eliminated and that the contents of the inhaler are mixed properly.

1. Hold the inhaler in a vertical position between your index and thumb fingers, placing your thumb on the base, below the mouthpiece.

1. Exhale as much as you can and then put the mouthpiece in your mouth, between your teeth, closing your lips around the device, but not biting it.

1. Immediately after starting to take air through your mouth, press the top of the inhaler to release the medication and continue to take air deeply and steadily.

1. Hold your breath and remove the inhaler from your mouth, removing your finger from the top of the inhaler. Continue to hold your breath for as long as you can.

1. If you are going to administer another inhalation, keep the inhaler in a vertical position and wait for about half a minute before repeating steps 3 to 7.

1. Put the mouthpiece cover back on by pushing firmly and adjusting it until you hear a click.

IMPORTANT

Do not perform steps 5, 6, and 7 quickly. It is important to start breathing in as slowly as possible, just before pressing the inhaler.

Practice in front of a mirror during the first few times. If you see a "mist" coming out of the top of the inhaler or the sides of your mouth, start again from step 2.

Patients who have difficulty coordinating the handling of the inhaler with inhalation may use a suitable spacer device (BABYHALER, spacer device for children up to 5 years).

Young children may need help, and their parents should handle the inhaler for them. Encourage the child to exhale and handle the inhaler just after the child starts to take air. Practice the technique together. Older children or people with fragile hands should hold the inhaler with both hands; they should put their two index fingers on the top of the inhaler and their two thumbs on the base, below the mouthpiece.

If your doctor has given you different instructions for using the inhaler, follow them carefully. Tell your doctor if you have any difficulties.

Cleaning:

Clean the inhaler at least once a week.

1. Remove the mouthpiece cover.
2. Do not remove the cartridge from the plastic casing.
3. Clean the mouthpiece from the inside and outside, as well as the plastic casing with a dry cloth, a paper towel, or a little cotton.
4. Put the mouthpiece cover back on.

DO NOT SUBMERGE THE METAL CONTAINER IN WATER.

Talk to your doctor or pharmacist if you have any doubts.

If you use more Beglan than you should

If you have used Beglan more than you should, you may notice: that your heart beats faster than usual, headache, tremors, increased blood pressure, low potassium levels in the blood, feeling of agitation and/or dizziness. Talk to your doctor or pharmacist immediately or the Toxicology Information Service, phone: 91 562 04 20. If the dose taken was very high, go to the doctor immediately or the Emergency Department of the nearest hospital. Take this package leaflet or the medicine with you.

If you forget to use Beglan

If you forget a dose, do not worry. Inhale a dose when you remember and then continue as before.

Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some people may be allergic to medicines. If you have any of the following symptoms soon after using Beglan, STOP using this medicine and tell your doctor immediately:

• Sudden onset of wheezing or chest tightness.
• Swelling of the eyelids, face, or lips.
• Rash (hives) or urticaria on any part of the body.

Some people, particularly those taking high doses of this type of medicine, may occasionally feel a little agitated, have a headache, or notice that their heart beats a bit faster than normal, but these effects usually disappear with continued treatment. If this feeling continues, tell your doctor, but do not stop treatment unless he tells you to.

The following are side effects associated with salmeterol. Tell your doctor if you have any of the following symptoms:

Common side effects(may affect up to 1 in 10 people)

• Tremors and headache. These are characteristic of this type of medication and usually disappear with time. Tremors occur more frequently if you receive doses higher than 50 micrograms, twice a day.
• Palpitations, which usually disappear with time.
• Muscle cramps.

Uncommon side effects (may affect up to 1 in 100 people)

• Hypersensitivity reactions with skin rash.
• Nervousness.
• Tachycardia (occurs more frequently if you receive doses higher than 50 micrograms, twice a day).

Rare side effects (may affect up to 1 in 1,000 people)

• Hypokalemia (low potassium levels in the blood).
• Insomnia.
• Dizziness.

Very rare side effects (may affect up to 1 in 10,000 people)

• Hypersensitivity reactions including edema (swelling) and angioedema (skin reaction with redness, swelling, itching, and difficulty breathing), bronchospasm (contraction of the bronchi causing difficulty breathing), and anaphylactic shock (severe allergic reaction).
• Hyperglycemia (high blood sugar levels). If you have diabetes, you may need to monitor your blood sugar levels more frequently and may need to adjust your diabetes treatment.
• Cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and extrasystoles (heart rhythm disorders).
• Irritation of the throat or pharynx, paradoxical bronchospasm (narrowing of the bronchi with decreased air intake and difficulty breathing).
• Nausea.
• Arthralgia (joint pain).
• Unspecific chest pain.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Beglan

Put the mouthpiece cover back on by pushing firmly and closing with a snap so that the cap is in place.

Keep this medicine out of the sight and reach of children.

Do not store above 30°C. Do not freeze.

Keep in the original packaging to protect from direct sunlight.

If the inhaler is very cold, remove the cartridge and warm it in your handfor a few minutes before use. Do not use any other method to warm it up.

The cartridge contains a pressurized liquid. Do not expose to temperatures above 50°C. Do not pierce, break, or burn the cartridge even if it is empty.

Do not use this medicine after the expiry date which is stated on the container after EXP. The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Beglan

• The active substance is 25 micrograms of salmeterol (as xinafoate) per application.
• The other ingredient is norflurane (HFA 134a).

This medicine contains fluorinated greenhouse gases.

Each inhaler contains 12 g of HFC-134a (also known as norflurane or HFA 134a) which corresponds to 0.0172 tons of CO2 equivalent (global warming potential GWP = 1,430).

Appearance of the product and contents of the pack

Beglan is an inhalation suspension in a pressurized container. Each inhaler provides 120 applications.

Marketing authorization holder and manufacturer

Marketing authorization holder:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Manufacturer:

Glaxo Wellcome Productions, S.A.S

23, Rue Lavoisier - Zone Industrielle Nº 2 (Evreux La Madeleine) - F-27000 - France

Date of last revision of this package leaflet:01/2025

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/